Efficacy of strategies to reduce mother-to-child HIV-1 transmission in Argentina, 1993-2000

Journal of Acquired Immune Deficiency Syndromes

Volumn 31, Issue 3, 2002, Pages 348-353

  Ceballos, Ana ^a   De Los Angeles Pando, María ^a   Liberatore, Diana ^a   Biglione, Mirna ^a   Cárdenas, Patricia Coll ^b   Martínez, Marina ^c   Celadilla, María Luisa ^d   Avila, María M ^a   Peralta, Liliana Martínez ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^c HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

^d Department of Hematology   (Argentina)

Author keywords

Diagnosis of HIV 1 infection; Pediatric HIV infection; Protocol ACTG 076.; Risk behaviors

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARGENTINA; ARTICLE; BREAST FEEDING; CESAREAN SECTION; CITY; FATHER; FEMALE; HEALTH EDUCATION; HEALTH PROGRAM; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; NEWBORN INFECTION; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; VERTICAL TRANSMISSION; VIRUS DIAGNOSIS;

EID: 0036840201     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200211010-00012     Document Type: Article

References (26)

1. UNAIDS. AIDS epidemic update: December 2001. Geneva: UNAIDS.
2. Boletín Sobre el SIDA en Argentina, junio 2001. Ministerio de Salud y Acción Social. Programa Nacional de Lucha contra los Retrovirus del humano y SIDA.
3. Connor EM, Sperling R, Gelbert R, et al. Reduction of maternalinfant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
4. Beckerman K, Morris A, Stek A. Mode of delivery and the risk of vertical transmission of HIV-1. N Engl J Med 1999;341:205-6.
5. Mofenson LM, McIntyre JA. Advances and research directions in the prevention of mother-to-child HIV-1 transmission. Lancet 2000;355:2237-44.
6. European Mode of Delivery Collaboration. Elective caesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomized clinical trial. Lancet 1999;353:1035-9.
7. Mandelbrot L. Pregnancy and HIV. Rev Prat 1999;49:1757-62.
8. Shapiro DE, Sperling RS, Mandelbrot L, et al. Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Obstet Gynecol 1999;94:897-908.
9. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996;335:1621-9.
10. Norma de SIDA en Perinatología, Propuesta Normativa Perinatal Programa Nacional de Lucha Contra los Retrovirus del Humano, SIDA y ETS. Ministerio de Salud y Acción Social de la Nación, República Argentina, 1997.
11. Liberatore D, Avila M, Calarota S, et al. Retrospective study of children born to HIV-1 infected mothers in a pediatric hospital in Argentina. Pediatr AIDS HIV Infect 1995;6:346-9.
12. Hollinger F, Bremer J, Myers L, et al. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J Clin Microbiol 1992;30:1787-94.
13. Albert J, Fenyo M. Simple, sensitive and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers. J Clin Microbiol 1990;28:1560-64.
14. Centers for Disease Control and Prevention. Revised classification system for HIV infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43(RR-12).
15. Wade N, Bvirkhead G, Warren B, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998;339:1409-14.
16. Cooper ER, Nugent RP, Diaz C, et al. After AIDS Clinical Trial 076: The changing pattern of zidovudine use during pregnancy and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. J Infect Dis 1996;174:1207-11.
17. Lindengren ML, Byers RH, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States: Success in reducing perinatal transmission. JAMA 1999;18:289-92.
18. Lallemont M, Jourdian G, Soyeon K, et al. Perinatal HIV Prevention Trial (PHPT), Thailand: DSMB recommends termination of short-short arm after first interim analysis [abstract 016]. 2nd Conference on Global Strategies for Prevention of HIV Transmission from Mothers to Infants, Montreal, September 1999.
19. International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: Meta-analysis of 15 prospective cohort studies. N Engl J Med 1999;340:977-87.
20. Ziegler JB, Cooper DA, Johnson RO, et al. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1985;1:896-7.
21. Lepage P, Van de Perre P, Carael M, et al. Postnatal transmission of HIV from mother to child. Lancet 1987;2:400-1.
22. Avila M, Gazpio M, Liberatore D, et al. Breast-feeding transmission of HIV-1. Medicina Buenos Aires 2000;60:302-4.
23. Leroy V, Newell M, Dabis F, et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet 1998;352:597-600.
24. Nduati R, Jhon G, Mbori-Ngacha D, et al. Effect of breast-feeding and formula feeding on transmission of HIV-1: A randomized clinical trial. JAMA 2000;283:1167-74.
25. Semba R, Kumwenda N, Hoover D, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 1999;180:93-8.
26. Orloff S, Bulterys M, Vink P, et al. Maternal characteristics associated with antenatal, intrapartum, and neonatal zidovudine use in four U.S. cities, 1994-1998. JAIDS 2001;28:65-72.